Inactive - find me on LinkedIn every now-and-again https://xitter.cf/t.co/j4g2MMZq3V
Columbus, OH
Joined December 2016
- Tweets4.3K
- Following1.7K
- Followers5.2K
- Likes12.7K
Daniel Stover, MD, FASCO retweeted
Training ride this pre @Pelotonia weekend in honor of Stephanie’s #TeamOfHope and to advance care and cures for #BreastCancer at the Stephanie Spielman Center @OSUCCC_James
Daniel Stover, MD, FASCO retweeted
Even HP was not tolerable for me as maintenance treatment for HER2+ MBC. The patient community calls Perjeta “poo-jeta” for a reason!
Indefinite T-DxD is not realistic- survivors will have to contend with long term SEs of ADCs (think ❤️& liver fx) #ASCO25 #bcsm
Agree! Also if we think in real world for our pts - maintenance HP (esp now we have a subq option) allow pts to not need a port, less frequent labs, less time spent in infusion, more time outside of cancer center
Looking forward to hearing pt perspectives!
@GRASPtweets @ASCO
Daniel Stover, MD, FASCO retweeted
Incredible to have @StoverLab giving a keynote lecture at the Harvard Breast and Gynecologic Cancer Symposium- what a thoughtful and practical approach to translational research in breast cancer
Daniel Stover, MD, FASCO retweeted
The @df_hcc Breast & Gynecologic Cancer Symposium started off with the J. Dirk Iglehart, M.D., Visiting Scholar Lecture given by Dr. Daniel Stover (@StoverLab) who discussed Translational Cancer Research: Data is the Answer and the Question.
dfhcc.harvard.edu/events/dfh…
Daniel Stover, MD, FASCO retweeted
Our Early Drug Development Unit it’s a brand new facility advancing the knowledge of new drugs and giving patients access to clinical trials. Great team from doctors, nurses, lab, research to administration working for our patients. @OSUCCC_James @OhioStateMedOnc @OSUWexMed
Daniel Stover, MD, FASCO retweeted
📣Had a great discussion this week @ASCO Daily News w/ Drs Charlotte Coles & Walter Weber on breast cancer locoregional tx updates #bcsm
✂️When can we omit ALND &/or SLNB?
💪How can we better prevent lymphedema?
☢️How can hypofractioned RT improve pt QOL?
dailynews.ascopubs.org/do/po…
Daniel Stover, MD, FASCO retweeted
Ask your lawmakers to support the Metastatic Breast Cancer (MBC) Access to Care Act, so those living with MBC do not have to wait for the treatments and financial support they require. The time to take action is now! p2a.co/mYuC11r #KomenAdvocacy
Daniel Stover, MD, FASCO retweeted
Join us! Looking forward to discussing opportunities for research during fellows & tips for navigating a successful research career! @HemOncFellows @RoswellHemOnc @OhioStateMedOnc @UAMSintmedicine @hemeoncfellow
Daniel Stover, MD, FASCO retweeted
Early detection of ovarian cancer using cell-free DNA fragmentomes and protein biomarkers | Cancer Discovery | American Association for Cancer Research @CD_AACR @isliquidbiopsy aacrjournals.org/cancerdisco…
Daniel Stover, MD, FASCO retweeted
Advances in breast cancer research come from knowing the patient journey. Every patient has a story to tell. @SusanGKomen is making a heroic effort to collect these patient journeys. If you are willing to donate your story, then please sign up komen.org/shareforcures/
Daniel Stover, MD, FASCO retweeted
Very good point! Integration of liquid biopsy and RECIST criteria is a need (LB-RECIST)
Here our paper on @Annals_Oncology addressing this concept
@mgoudaMD @VivekSubbiah @curijoey
annalsofoncology.org/article…
Daniel Stover, MD, FASCO retweeted
Join @DrGattiMays on Saturday, September 21 @ 7:30 PM EST!
📣 Saturday, September 21 @ 7:30 PM EST on MedNews Week!🩺
We are excited to be Shining the Spotlight on the work of Global Innovator & Keynote Speaker, 🌟Dr. Margaret Gatti-Mays🌟
Hope to see you there!
Event link: onclive.com/mednews-events?d…
Daniel Stover, MD, FASCO retweeted
📣 NEW #OncTwitter 🇺🇸
Ribociclib is now FDA-approved for treatment of adults with stage 2 & 3 hormone receptor positive, HER2 negative #breastcancer at high risk of recurrence based on efficacy & safety results of the NATALEE trial.
#bcsm #regulatory #ESMO24
Daniel Stover, MD, FASCO retweeted
#CAPItello290 is negative👎- paclitaxel +/- capiva in 1L #TNBC @hmcarthur
📍OS 🟰 in all comers & pts w/ PIK3/AKT/PTEN mut (30% of pts) w/ and w/o capi
📌PFS numerically ⬆️ in altered pop 5.6 vs. 7.5 mo
Not without toxicity either 💩
#ESMO24
#ESMOAmbassadors
#bcsm
Daniel Stover, MD, FASCO retweeted
📢 Happy to see our study on Inflammatory “Dietary Pattern and Mammographic Features” using Nurses’s Health study I and II cohort is online now in The Journal of Nutrition @SOJ_Nutritional @StoverLab @rtamimi @WCMPopHealthSci sciencedirect.com/science/ar…
Daniel Stover, MD, FASCO retweeted
Phase I/Ib trial-Inavolisib + Palbociclib + ET for PIK3CAm HR+ HER2- MBC now published .@OncoAlert @MSKCancerCenter @MSK_DeptOfMed @JCO_ASCO ascopubs.org/doi/10.1200/JCO… #bcsm
Daniel Stover, MD, FASCO retweeted
👋Welcome @royaryam to the @OSUCCC_James Medical Oncology team! We are excited to work with you!
Daniel Stover, MD, FASCO retweeted
A beautifully crafted review “Towards targeting the breast cancer immune microenvironment” in @NatureRevCancer by @LoiSher et al not only closes a gap in our up to date understanding of immune microenvironment, but is graphically 🔝
Bravo. Required read.
nature.com/articles/s41568-0…
